Skip to main content
Erschienen in: Annals of Surgical Oncology 6/2008

Open Access 01.06.2008 | Bone and Soft Tissue Sarcomas

Knowledge Helps, but Alone It Is Not Enough

verfasst von: Murray F. Brennan, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2008

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
To the Editor:
The understanding of soft tissue sarcoma has progressed impressively in the last two decades. Delineation of the biology, molecular diagnosis, and outcome have been carefully characterized with defined prognostic indicators. The challenge has been to identify if biology can predict behavior; that has now been clearly established. More importantly, can biology and predictive outcome mandate treatment change, and finally can treatment, based on biology and known outcome, be altered to reflect improved outcome?
Dr Pollock and his coauthors examine this question by defining retroperitoneal liposarcoma into well-differentiated (WD) and dedifferentiated (DD) subtypes.1 They examined 135 patients over the last 10 years at their institution. This significant experience in a major sarcoma center allows important observations. As expected, WD was mostly primary and DD was mostly recurrent. Chemotherapy was rarely used in WD, and more aggressive resection was required in DD, while a third to half of all patients required multivisceral resection. The initial complete gross resection was obtained in both groups, and, as expected, recurrence was greater in the dedifferentiated group. As previously identified, metastatic disease is rare in well-differentiated liposarcoma and local recurrence can be late and prolonged.
While the title of the present manuscript, “Two Different Diseases Possibly Requiring Different Treatment Approaches,” is most enticing, the data predominantly confirm that accurate diagnosis of histological subtype predicts recurrence. A recent nomogram based on 800 patients with liposarcoma has confirmed the importance of histological subtype.1 Few would challenge the authors questioning of whether, with such different outcomes, treatment should be different; however, how different is different? The real challenge, alluded to in the title, is what “different” treatment should be applied to these “different” diseases. The authors are clearly aware of the different outcomes, and that has already affected management. In both groups radiation is minimally used (<20%), whereas chemotherapy is essentially never used in the well-differentiated type and used in the dedifferentiated type in the majority (73%). However, the benefits of such different approaches are unclear. Despite aggressive use of multimodality therapy, outcome remains poor with 5-year survival in DD at 37%. This is similar to that reported by Dalal et al. at 39%.2
Unfortunately, the real challenge remains; we can increasingly improve the accuracy of histological diagnosis, molecular characterization, and prediction of outcome, but we are far less sanguine about improvements in treatment that translate into better survival. Importantly, the reverse is true. We are now aware that we can diminish the aggressivity of surgical approaches when the biology is favorable and the consequence of recurrence limited. The authors confirm that less aggressive surgical approaches for WD are appropriate. The presence of WD liposarcoma especially an asymptomatic locally recurrent lesion does not mandate operation! It is fortunate that our knowledge increases and unfortunate that we cannot transfer that increase of knowledge into more effective therapy. We take some consolation in the fact that we can decrease morbidity of surgical therapy by better understanding of biology.
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License ( https://​creativecommons.​org/​licenses/​by-nc/​2.​0 ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
download
DOWNLOAD
print
DRUCKEN

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

© Springer Medizin

Bis 11. April 2024 bestellen und im ersten Jahr 50 % sparen!

Literatur
1.
Zurück zum Zitat Lahat G, Anaya DA, Wang X, et al. Resectable well differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches. Ann Surg Oncol 2008; 15 (DOI: 10.1245/s10434-007-9805-x) Lahat G, Anaya DA, Wang X, et al. Resectable well differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches. Ann Surg Oncol 2008; 15 (DOI: 10.​1245/​s10434-007-9805-x)
2.
Zurück zum Zitat Dalal KM, Kattan MW, Antonescu CR, et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 2006; 244:381–91.PubMed Dalal KM, Kattan MW, Antonescu CR, et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 2006; 244:381–91.PubMed
Metadaten
Titel
Knowledge Helps, but Alone It Is Not Enough
verfasst von
Murray F. Brennan, MD
Publikationsdatum
01.06.2008
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2008
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-9855-8

Weitere Artikel der Ausgabe 6/2008

Annals of Surgical Oncology 6/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.